Managing ANDA Venue Issues As Del. And NJ Filings Rise
In 2023, pharmaceutical patent owners filed nearly 250 infringement complaints against generic drug manufacturers. More than 90% of those cases were filed in the Districts of Delaware or New Jersey....To view the full article, register now.
Already a subscriber? Click here to view full article